PubMed Health⌕ Search

PubMed · 8262750

Large-tip-angle spin-echo imaging. Theory and applications.

Abstract

RATIONALE AND OBJECTIVES: Tissue contrast phenomenology was investigated analytically and clinically for a class of magnetic resonance (MR) pulse sequences we call large-tip-angle (LTA) spin-echo (SE) imaging. In comparison to traditional SE sequences (denoted 90 degrees-180 degrees-echo), the LTA sequence is of the form alpha degrees-180 degrees-echo, where 90 degrees < alpha < 180 degrees. Theoretical analysis shows that appropriately designed LTA sequences can selectively boost the MR signal by 10%-150% in substances whose spin lattice (T1) relaxation values equal or exceed the sequence repetition time (TR). This unique contrast behavior potentially allows one to reduce TR (and hence imaging time) by 30% to 50% while maintaining constant T2-weighted contrast or contrast-to-noise within an image. METHODS: Preliminary clinical testing of LTA sequences was performed in 60 patients with a wide range of cranial, spinal, musculoskeletal, and abdominal pathologies. Large-tip-angle images (1,500/80/130 degrees) were blindly and prospectively compared to conventional (2,600/80/90 degrees) SE images. RESULTS: Principal diagnoses were concordant between the readers in all cases, although minor variances in detail features were noted in 6 (10%) of 60 cases. Large-tip-angle sequences revealed small cystic areas in two cerebral neoplasms and in a herniated disk which were not apparent on the standard SE images. However, the LTA images were rated to be "noisier" by visual assessment in 43 of 60 cases, the exception being for abdominal examinations, where respiratory and peristaltic artifacts were judged more severe on the standard SE sequences. CONCLUSIONS: Large-tip-angle SE imaging is an interesting technique capable of improving image contrast and signal from lesions with long T1 values when the sequence repetition time (TR) is short.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A D Elster, T J Provost. 1993. Large-tip-angle spin-echo imaging. Theory and applications.. https://doi.org/10.1097/00004424-199310000-00017

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A MAGIBU-based model for pediatric and juvenile CNS tumors: an in-house epigenetic decision-support framework compared with online DNA methylation classifiers.

Background: DNA methylation profiling is a tool that provides key support for central nervous system (CNS) tumor classification. However, diagnostically ambiguous pediatric cases may result in discordant outputs across classifiers. We developed MAGIBU, a cross-platform, projection-based framework that embeds individual methylomes into a fixed CNS reference landscape, ranking diagnostic entities by local epigenetic proximity to support clinician-led integrative diagnosis. Methods: As a proof-of-concept, we evaluated MAGIBU in eight morphologically challenging pediatric/juvenile CNS tumors with unresolved diagnoses after institutional and central pathology review. To establish a benchmark in the absence of a definitive histopathological ground truth, a consensus epigenetic reference was defined a priori for cases showing concordant results between the Heidelberg CNS Tumor Methylation Classifier and Methylscape Analysis. Comparisons were also performed with Epigenomic Digital Pathology (EpiDiP). To validate MAGIBU beyond this discovery cohort, performance was assessed at the family level across the CNS methylation spectrum (n = 678, 28 methylation families), on non-array platforms (whole-genome bisulfite sequencing and Oxford Nanopore), and in a focused analysis of the low-grade glioma and diffuse midline glioma compartment across four independent cohorts (n = 670). Results: In the discovery cohort, MAGIBU achieved high concordance with the consensus reference (Cohen's &#x3ba; = 0.855), outperforming EpiDiP (&#x3ba; = 0.278), which frequently placed low-grade tumors in proximity to higher-grade reference regions. Conclusions: MAGIBU provides a stable, quantitative differential diagnosis framework that mitigates the limitations of rigid categorical assignments. By leveraging a distance-based proximity metric, it offers a transparent decision-support tool that integrates effectively with clinical, radiological, and molecular data. While performance is inherently dependent on reference atlas composition, MAGIBU represents a robust complementary approach for the diagnostic workup of ambiguous CNS tumors.

Brain↗

1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans.

Low-frequency 1q21.1 distal deletion and duplication copy number variant (CNV) carriers are predisposed to multiple neurodevelopmental disorders, including schizophrenia, autism and intellectual disability. Human carriers display a high prevalence of micro- and macrocephaly in deletion and duplication carriers, respectively. The underlying brain structural diversity remains largely unknown. We systematically called CNVs in 38 cohorts from the large-scale ENIGMA-CNV collaboration and the UK Biobank and identified 28 1q21.1 distal deletion and 22 duplication carriers and 37,088 non-carriers (48% male) derived from 15 distinct magnetic resonance imaging scanner sites. With standardized methods, we compared subcortical and cortical brain measures (all) and cognitive performance (UK Biobank only) between carrier groups also testing for mediation of brain structure on cognition. We identified positive dosage effects of copy number on intracranial volume (ICV) and total cortical surface area, with the largest effects in frontal and cingulate cortices, and negative dosage effects on caudate and hippocampal volumes. The carriers displayed distinct cognitive deficit profiles in cognitive tasks from the UK Biobank with intermediate decreases in duplication carriers and somewhat larger in deletion carriers-the latter potentially mediated by ICV or cortical surface area. These results shed light on pathobiological mechanisms of neurodevelopmental disorders, by demonstrating gene dose effect on specific brain structures and effect on cognitive function.

Brain↗